Outsourced Pharma Webinars

  1. Common Tablet Defects And The Importance Of Blending 2/21/2025

    Learn to minimize tablet defects like picking, sticking, and capping. This webinar explores common issues and the critical role of blending in achieving quality tablets.

  2. Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs 2/20/2025

    Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

  3. Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates 2/20/2025

    Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.

  4. From Research To Reality: Overcoming CMC Challenges In Cell & Gene Therapy 2/20/2025

    Explore the importance of adopting a Quality by Design (QbD) approach in the development process while integrating regulatory and CMC strategies for maximum efficiency and benefit.

  5. Mastering QbD For Successful Process Validation Campaigns And Commercial Manufacturing Of Biologics 2/18/2025

    In this presentation, industry-leading bioprocess experts explore the challenges and opportunities that arise when implementing Quality by Design (QbD) in biologics development and manufacturing.

  6. De-Risking Early Phase Micronization With Integrated Solid Form Selection 2/18/2025

    Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.

  7. Contract Manufacturing: Must-Know Trends And Strategies For 2025 2/12/2025

    Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.

  8. Purity As A Priority: Optimizing Safety Measures For rAAV Therapies 2/11/2025

    Watch to learn how rAAV vectors in gene therapy are addressing manufacturing impurities, risks to patient safety, and analytical methods for detection while aiding sponsors in regulatory compliance.

  9. CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs 2/6/2025

    In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

  10. LBA Vs. LC-MS: Competing Technologies At A Development Crossroad 2/6/2025

    Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.